Study of in vitro and in vivo effects of 1,6-Bis[4-(4-amino-3-hydroxyphenoxy)phenyl]diamantane (DPD), a novel cytostatic and differentiation inducing agent, on human colon cancer cells
2003

Effects of a New Drug on Colon Cancer Cells

Sample size: 10 publication Evidence: moderate

Author Information

Author(s): Wang J J, Chang Y F, Chern Y T, Chi C W

Primary Institution: National Taipei College of Nursing

Hypothesis

Can DPD effectively inhibit the growth and induce differentiation in human colon cancer cells?

Conclusion

DPD significantly inhibits the growth of colon cancer cells and promotes their differentiation without causing acute toxicity in vivo.

Supporting Evidence

  • DPD produced G1 arrest in colon cancer cells.
  • DPD increased expression of differentiation markers CEA and FN.
  • In vivo, DPD significantly reduced tumor growth in xenograft models.

Takeaway

A new drug called DPD helps stop colon cancer cells from growing and makes them behave more like normal cells.

Methodology

The study evaluated the effects of DPD on three colon cancer cell lines in vitro and in vivo using xenograft models.

Limitations

The study primarily focused on three specific colon cancer cell lines, which may limit the generalizability of the findings.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1038/sj.bjc.6601337

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication